サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：動物用疼痛管理薬の世界市場（2022年～2028年）
市場調査レポート
商品コード
1215725

動物用疼痛管理薬の世界市場（2022年～2028年）

Veterinary Pain Management Drugs Market 2022-2028
出版日: | 発行: Orion Market Research | ページ情報: 英文 | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
動物用疼痛管理薬の世界市場（2022年～2028年）
出版日: 2023年01月14日
発行: Orion Market Research
ページ情報: 英文
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の動物用疼痛管理薬の市場規模は、予測期間中に3.8%のCAGRで大きく成長すると予測されています。

動物の健康と福祉を維持したいと考えるペット所有者の傾向の増加、市場成長に影響する著名企業による、より良くパーソナライズされた薬剤の開発などが、世界の動物用疼痛管理薬市場の成長促進要因です。また、がんや腹痛、神経障害性疼痛に苦しむ家畜の数が大幅に拡大していることも、市場成長にプラスの影響を及ぼしています。

当レポートでは、世界の動物用疼痛管理薬市場について調査分析し、市場概要、セグメント・地域別の市場分析、競合情勢、企業プロファイルなど、体系的な情報を提供しています。

目次

第1章 レポートの概要

第2章 市場概要と洞察

  • 調査範囲
  • アナリストの洞察と現在の市場動向

第3章 競合情勢

  • 主要企業分析
    • Zoetis Inc.
    • Merck & Co., Inc.
    • BASF SE
  • 主要戦略分析

第4章 市場内訳

  • 世界の動物用疼痛管理薬市場：タイプ別
    • NSAID（非ステロイド性抗炎症薬）
    • アゴニスト
    • 麻酔薬
    • オピオイド
    • DMOAD（疾患修飾性変形性関節症治療薬）
    • その他
  • 世界の動物用疼痛管理薬市場：動物タイプ別
    • ペット
    • 家畜動物
  • 世界の動物用疼痛管理薬市場：用途別
    • 変形性関節症
    • 筋骨格系疾患
    • がん
    • その他
  • 世界の動物用疼痛管理薬市場：流通チャネル別
    • 動物病院
    • 動物クリニック
    • その他

第5章 地域分析

  • 北米
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • イタリア
    • スペイン
    • フランス
    • その他欧州
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • 韓国
    • その他アジア太平洋
  • その他の地域
    • ラテンアメリカ
    • 中東・アフリカ

第6章 企業プロファイル

  • Assisi Animal Health
  • Bayer AG
  • Boehringer Ingelheim International GmbH
  • Cargill Inc.
  • Ceva Sante Animale
  • Chanelle Pharma
  • Dechra Pharmaceuticals
  • Elanco Animal Health Inc.
  • Eli Lilly and Co.
  • Evonik Industries AG
  • Idexx Laboratories Inc.
  • Kemin Industries, Inc
  • Norbrook Laboratories Ltd.
  • Sumitomo Chemical Co. Ltd.
  • Vetoquinol S.A
図表

LIST OF TABLES

  • 1. GLOBAL VETERINARY PAIN MANAGEMENT DRUGS MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
  • 2. GLOBAL NSAIDS VETERINARY PAIN MANAGEMENT DRUGS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 3. GLOBAL AGONISTS VETERINARY PAIN MANAGEMENT DRUGS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 4. GLOBAL ANESTHETICS VETERINARY PAIN MANAGEMENT DRUGS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 5. GLOBAL OPIOIDS VETERINARY PAIN MANAGEMENT DRUGS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 6. GLOBAL DMOADS VETERINARY PAIN MANAGEMENT DRUGS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 7. GLOBAL OTHER VETERINARY PAIN MANAGEMENT DRUGS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 8. GLOBAL VETERINARY PAIN MANAGEMENT DRUGS MARKET RESEARCH AND ANALYSIS BY ANIMAL TYPE, 2021-2028 ($ MILLION)
  • 9. GLOBAL VETERINARY PAIN MANAGEMENT DRUGS FOR COMPANION ANIMALS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 10. GLOBAL VETERINARY PAIN MANAGEMENT DRUGS FOR LIVESTOCK ANIMALS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 11. GLOBAL VETERINARY PAIN MANAGEMENT DRUGS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
  • 12. GLOBAL VETERINARY PAIN MANAGEMENT DRUGS IN OSTEOARTHRITIS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 13. GLOBAL VETERINARY PAIN MANAGEMENT DRUGS IN MUSCULOSKELETAL DISORDERS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 14. GLOBAL VETERINARY PAIN MANAGEMENT DRUGS IN CANCER MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 15. GLOBAL VETERINARY PAIN MANAGEMENT DRUGS IN OTHER APPLICATIONS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 16. GLOBAL VETERINARY PAIN MANAGEMENT DRUGS MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2021-2028 ($ MILLION)
  • 17. GLOBAL VETERINARY PAIN MANAGEMENT DRUGS IN VETERINARY HOSPITALS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 18. GLOBAL VETERINARY PAIN MANAGEMENT DRUGS IN VETERINARY CLINICS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 19. GLOBAL VETERINARY PAIN MANAGEMENT DRUGS IN OTHER DISTRIBUTION CHANNELS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 20. GLOBAL VETERINARY PAIN MANAGEMENT DRUGS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 21. NORTH AMERICAN VETERINARY PAIN MANAGEMENT DRUGS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
  • 22. NORTH AMERICAN VETERINARY PAIN MANAGEMENT DRUGS MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
  • 23. NORTH AMERICAN VETERINARY PAIN MANAGEMENT DRUGS MARKET RESEARCH AND ANALYSIS BY ANIMAL TYPE, 2021-2028 ($ MILLION)
  • 24. NORTH AMERICAN VETERINARY PAIN MANAGEMENT DRUGS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
  • 25. NORTH AMERICAN VETERINARY PAIN MANAGEMENT DRUGS MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2021-2028 ($ MILLION)
  • 26. EUROPEAN VETERINARY PAIN MANAGEMENT DRUGS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
  • 27. EUROPEAN VETERINARY PAIN MANAGEMENT DRUGS MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
  • 28. EUROPEAN VETERINARY PAIN MANAGEMENT DRUGS MARKET RESEARCH AND ANALYSIS BY ANIMAL TYPE, 2021-2028 ($ MILLION)
  • 29. EUROPEAN VETERINARY PAIN MANAGEMENT DRUGS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
  • 30. EUROPEAN VETERINARY PAIN MANAGEMENT DRUGS MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2021-2028 ($ MILLION)
  • 31. ASIA-PACIFIC VETERINARY PAIN MANAGEMENT DRUGS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
  • 32. ASIA-PACIFIC VETERINARY PAIN MANAGEMENT DRUGS MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
  • 33. ASIA-PACIFIC VETERINARY PAIN MANAGEMENT DRUGS MARKET RESEARCH AND ANALYSIS BY ANIMAL TYPE, 2021-2028 ($ MILLION)
  • 34. ASIA-PACIFIC VETERINARY PAIN MANAGEMENT DRUGS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
  • 35. ASIA-PACIFIC VETERINARY PAIN MANAGEMENT DRUGS MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2021-2028 ($ MILLION)
  • 36. REST OF THE WORLD VETERINARY PAIN MANAGEMENT DRUGS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
  • 37. REST OF THE WORLD VETERINARY PAIN MANAGEMENT DRUGS MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
  • 38. REST OF THE WORLD VETERINARY PAIN MANAGEMENT DRUGS MARKET RESEARCH AND ANALYSIS BY ANIMAL TYPE, 2021-2028 ($ MILLION)
  • 39. REST OF THE WORLD VETERINARY PAIN MANAGEMENT DRUGS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
  • 40. REST OF THE WORLD VETERINARY PAIN MANAGEMENT DRUGS MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2021-2028 ($ MILLION)

LIST OF FIGURES

  • 1. GLOBAL VETERINARY PAIN MANAGEMENT DRUGS MARKET SHARE BY TYPE, 2021 VS 2028 (%)
  • 2. GLOBAL VETERINARY PAIN MANAGEMENT DRUGS MARKET SHARE BY ANIMAL TYPE, 2021 VS 2028 (%)
  • 3. GLOBAL VETERINARY PAIN MANAGEMENT DRUGS MARKET SHARE BY APPLICATION, 2021 VS 2028 (%)
  • 4. GLOBAL VETERINARY PAIN MANAGEMENT DRUGS MARKET SHARE BY DISTRIBUTION CHANNEL, 2021 VS 2028 (%)
  • 5. GLOBAL VETERINARY PAIN MANAGEMENT DRUGS MARKET SHARE BY REGION, 2021 VS 2028 (%)
  • 6. GLOBAL NSAIDS VETERINARY PAIN MANAGEMENT DRUGS MARKET SHARE BY REGION, 2021 VS 2028 (%)
  • 7. GLOBAL AGONISTS VETERINARY PAIN MANAGEMENT DRUGS MARKET SHARE BY REGION, 2021 VS 2028 (%)
  • 8. GLOBAL ANESTHETICS VETERINARY PAIN MANAGEMENT DRUGS MARKET SHARE BY REGION, 2021 VS 2028 (%)
  • 9. GLOBAL OPIOIDS VETERINARY PAIN MANAGEMENT DRUGS MARKET SHARE BY REGION, 2021 VS 2028 (%)
  • 10. GLOBAL DMOADS VETERINARY PAIN MANAGEMENT DRUGS MARKET SHARE BY REGION, 2021 VS 2028 (%)
  • 11. GLOBAL OTHER VETERINARY PAIN MANAGEMENT DRUGS MARKET SHARE BY REGION, 2021 VS 2028 (%)
  • 12. GLOBAL VETERINARY PAIN MANAGEMENT DRUGS FOR COMPANION ANIMALS MARKET SHARE BY REGION, 2021 VS 2028 (%)
  • 13. GLOBAL VETERINARY PAIN MANAGEMENT DRUGS FOR LIVESTOCK ANIMALS MARKET SHARE BY REGION, 2021 VS 2028 (%)
  • 14. GLOBAL VETERINARY PAIN MANAGEMENT DRUGS IN OSTEOARTHRITIS MARKET SHARE BY REGION, 2021 VS 2028 (%)
  • 15. GLOBAL VETERINARY PAIN MANAGEMENT DRUGS IN MUSCULOSKELETAL DISORDERS MARKET SHARE BY REGION, 2021 VS 2028 (%)
  • 16. GLOBAL VETERINARY PAIN MANAGEMENT DRUGS IN CANCER MARKET SHARE BY REGION, 2021 VS 2028 (%)
  • 17. GLOBAL VETERINARY PAIN MANAGEMENT DRUGS IN OTHER APPLICATIONS MARKET SHARE BY REGION, 2021 VS 2028 (%)
  • 18. GLOBAL VETERINARY PAIN MANAGEMENT DRUGS IN VETERINARY HOSPITALS MARKET SHARE BY REGION, 2021 VS 2028 (%)
  • 19. GLOBAL VETERINARY PAIN MANAGEMENT DRUGS IN CLINICS MARKET SHARE BY REGION, 2021 VS 2028 (%)
  • 20. GLOBAL VETERINARY PAIN MANAGEMENT DRUGS IN OTHER DISTRIBUTION CHANNELS MARKET SHARE BY REGION, 2021 VS 2028 (%)
  • 21. GLOBAL VETERINARY PAIN MANAGEMENT DRUGS MARKET SHARE BY REGION, 2021 VS 2028 (%)
  • 22. US VETERINARY PAIN MANAGEMENT DRUGS MARKET SIZE, 2021-2028 ($ MILLION)
  • 23. CANADA VETERINARY PAIN MANAGEMENT DRUGS MARKET SIZE, 2021-2028 ($ MILLION)
  • 24. UK VETERINARY PAIN MANAGEMENT DRUGS MARKET SIZE, 2021-2028 ($ MILLION)
  • 25. FRANCE VETERINARY PAIN MANAGEMENT DRUGS MARKET SIZE, 2021-2028 ($ MILLION)
  • 26. GERMANY VETERINARY PAIN MANAGEMENT DRUGS MARKET SIZE, 2021-2028 ($ MILLION)
  • 27. ITALY VETERINARY PAIN MANAGEMENT DRUGS MARKET SIZE, 2021-2028 ($ MILLION)
  • 28. SPAIN VETERINARY PAIN MANAGEMENT DRUGS MARKET SIZE, 2021-2028 ($ MILLION)
  • 29. REST OF EUROPE VETERINARY PAIN MANAGEMENT DRUGS MARKET SIZE, 2021-2028 ($ MILLION)
  • 30. INDIA VETERINARY PAIN MANAGEMENT DRUGS MARKET SIZE, 2021-2028 ($ MILLION)
  • 31. CHINA VETERINARY PAIN MANAGEMENT DRUGS MARKET SIZE, 2021-2028 ($ MILLION)
  • 32. JAPAN VETERINARY PAIN MANAGEMENT DRUGS MARKET SIZE, 2021-2028 ($ MILLION)
  • 33. SOUTH KOREA VETERINARY PAIN MANAGEMENT DRUGS MARKET SIZE, 2021-2028 ($ MILLION)
  • 34. REST OF ASIA-PACIFIC VETERINARY PAIN MANAGEMENT DRUGS MARKET SIZE, 2021-2028 ($ MILLION)
  • 35. REST OF THE WORLD VETERINARY PAIN MANAGEMENT DRUGS MARKET SIZE, 2021-2028 ($ MILLION)
目次
Product Code: OMR2026781

Title:Global Veterinary Pain Management Drugs Market Size, Share, and Trends Analysis Report, by Type (NSAIDs, Agonists, Anesthetics, Opioids, DMOADs, and Others), By Animal Type (Companion Animals and Livestock Animals), By Application (Osteoarthritis, Musculoskeletal Disorders, Cancer, and Others), By Distribution Channel (Veterinary Hospitals, Veterinary Clinics, and Others), Forecast Period (2022-2028).

The global veterinary pain management drugs market is anticipated to grow at a substantial CAGR of 3.8% during the forecast period. The global veterinary pain management drugs market growth is driven by the factors such as rising pet owners' inclination toward maintaining animal health and welfare, and the development of better-personalized drugs by prominent players operating in market growth. A significant increase in the livestock population suffering from cancer, and abdominal and neuropathic pain is also creating a positive scope for market growth. According to the American Veterinary Medical Association, nearly 1 in 4 dogs will, at some stage in their life, develop neoplasia. Almost half of the dogs over the age of 10 will develop cancer. Significant investment by pet owners in animal healthcare is the factor motivating drug manufacturers to increase their R&D activities for better drug development. As per the American Pet Products Association, in 2019, annual spending on pets reached nearly $95.7 billion, and animal product sales reached around $100 billion.

The global veterinary pain management drugs market is segmented based on type, animal type, application, and distribution channel. Based on type, the market is sub-segmented into NSAIDs, agonists, anesthetics, opioids, DMOAD, and others. Based on animal type, the market is bifurcated into companion animals and livestock animals. Based on application, the market is sub-segmented into osteoarthritis, musculoskeletal disorders, cancer, and others. Whereas based on distribution channels, the market is further categorized into veterinary hospitals, veterinary clinics, and others.

Geographically, the veterinary pain management drugs market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World. North America is likely to hold the highest share in the market due to the huge consumption of dairy products that has surged the number of animals. That further led to the generation of animal diseases. Moreover, many companies in the region are launching new products in the market. For instance, in 2020, Carprofen Chewable Tablets was developed by Cronus Pharma Specialties and approved by the USFDA.

The major market players in the global veterinary pain management drugs market include Zoetis Inc., Merck & Co., Inc., BASF SE, Bayer AG, Boehringer Ingelheim International GmbH, Cargill Inc., Elanco Animal Health Inc., and Eli Lilly and Co., among others. The market players are also contributing significantly to the growth of the market by the adoption of various strategies including mergers and acquisitions, geographical expansion, partnerships, collaborations, and new product launches, to stay competitive in the market.

Research Methodology

The market study of the global veterinary pain management drugs is incorporated by extensive primary and secondary research conducted by the research team at OMR. Secondary research has been conducted to refine the available data to break down the market into various segments, and derive the total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macroeconomic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports.

Secondary Sources Include:

  • Financial reports of companies involved in the market.
  • Whitepapers, research papers, and news blogs.
  • Company websites and their product catalog.

The report provides an in-depth analysis of the market size and intended quality of the service preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models.

Market Segmentation

  • Global Veterinary Pain Management Drugs Research and Analysis by Type
  • Global Veterinary Pain Management Drugs Research and Analysis by Animal Type
  • Global Veterinary Pain Management Drugs Research and Analysis by Application
  • Global Veterinary Pain Management Drugs Research and Analysis by Distribution Channel

The Report Covers:

  • Comprehensive research methodology of the global veterinary pain management drugs market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the global veterinary pain management drugs market.
  • Insights about market determinants that are stimulating the global veterinary pain management drugs market.
  • Detailed and extensive market segments with the regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.

Table of Contents

1. Report Summary

  • Current Industry Analysis and Growth Potential Outlook
  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Region

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion

3. Competitive Landscape

  • 3.1. Key Company Analysis
    • 3.1.1. Zoetis Inc.
      • 3.1.1.1. Overview
      • 3.1.1.2. Financial Analysis
      • 3.1.1.3. SWOT Analysis
      • 3.1.1.4. Recent Developments
    • 3.1.2. Merck & Co., Inc.
      • 3.1.2.1. Overview
      • 3.1.2.2. Financial Analysis
      • 3.1.2.3. SWOT Analysis
      • 3.1.2.4. Recent Developments
    • 3.1.3. BASF SE
      • 3.1.3.1. Overview
      • 3.1.3.2. Financial Analysis
      • 3.1.3.3. SWOT Analysis
      • 3.1.3.4. Recent Developments
  • 3.2. Key Strategy Analysis

4. Market Segmentation

  • 4.1. Global Veterinary Pain Management Drugs Market by Type
    • 4.1.1. NSAIDs (Nonsteroidal Anti-inflammatory Drugs)
    • 4.1.2. Agonists
    • 4.1.3. Anesthetics
    • 4.1.4. Opioids
    • 4.1.5. DMOADs (Disease-Modifying Osteoarthritis Drug)
    • 4.1.6. Others
  • 4.2. Global Veterinary Pain Management Drugs Market by Animal Type
    • 4.2.1. Companion Animal
    • 4.2.2. Livestock Animal
  • 4.3. Global Veterinary Pain Management Drugs Market by Application
    • 4.3.1. Osteoarthritis
    • 4.3.2. Musculoskeletal Disorders
    • 4.3.3. Cancer
    • 4.3.4. Others
  • 4.4. Global Veterinary Pain Management Drugs Market by Distribution Channel
    • 4.4.1. Veterinary Hospitals
    • 4.4.2. Veterinary Clinics
    • 4.4.3. Others

5. Regional Analysis

  • 5.1. North America
    • 5.1.1. United States
    • 5.1.2. Canada
  • 5.2. Europe
    • 5.2.1. UK
    • 5.2.2. Germany
    • 5.2.3. Italy
    • 5.2.4. Spain
    • 5.2.5. France
    • 5.2.6. Rest of Europe
  • 5.3. Asia-Pacific
    • 5.3.1. China
    • 5.3.2. India
    • 5.3.3. Japan
    • 5.3.4. South Korea
    • 5.3.5. Rest of Asia-Pacific
  • 5.4. Rest of the World
    • 5.4.1. Latin America
    • 5.4.2. Middle East & Africa

6. Company Profiles

  • 6.1. Assisi Animal Health
  • 6.2. Bayer AG
  • 6.3. Boehringer Ingelheim International GmbH
  • 6.4. Cargill Inc.
  • 6.5. Ceva Sante Animale
  • 6.6. Chanelle Pharma
  • 6.7. Dechra Pharmaceuticals
  • 6.8. Elanco Animal Health Inc.
  • 6.9. Eli Lilly and Co.
  • 6.10. Evonik Industries AG
  • 6.11. Idexx Laboratories Inc.
  • 6.12. Kemin Industries, Inc
  • 6.13. Norbrook Laboratories Ltd.
  • 6.14. Sumitomo Chemical Co. Ltd.
  • 6.15. Vetoquinol S.A